Advertisement

Advertisement

GB:TCF Stock Latest News

TheraCryf Advances Lead Addiction Drug to Final Preclinical Toxicology Milestone

Company AnnouncementsTheraCryf Advances Lead Addiction Drug to Final Preclinical Toxicology Milestone

TheraCryf Secures Final Major Ox‑1 Patent and Advances Addiction Drug Towards Clinical Stage

PremiumCompany Announcements

TheraCryf Secures Final Major Ox‑1 Patent and Advances Addiction Drug Towards Clinical Stage

3M ago

TheraCryf Hits Key Manufacturing Milestone for Ox-1 Addiction Candidate

PremiumCompany Announcements

TheraCryf Hits Key Manufacturing Milestone for Ox-1 Addiction Candidate

3M ago

TheraCryf Announces Progress on Preclinical Fatigue Treatment Program

PremiumCompany Announcements

TheraCryf Announces Progress on Preclinical Fatigue Treatment Program

4M ago

TheraCryf Advances Addiction Treatment Program with Strategic Developments

PremiumCompany Announcements

TheraCryf Advances Addiction Treatment Program with Strategic Developments

4M ago

TheraCryf Advances Ox-1 Program Amidst Addiction Awareness Week

PremiumCompany AnnouncementsTheraCryf Advances Ox-1 Program Amidst Addiction Awareness Week

5M ago

TheraCryf Advances Addiction Treatment Program Amidst Awareness Week

Company Announcements

TheraCryf Advances Addiction Treatment Program Amidst Awareness Week

5M ago

TheraCryf plc to Announce Half-Year Results on 3 December 2025

Company Announcements

TheraCryf plc to Announce Half-Year Results on 3 December 2025

5M ago

TheraCryf Achieves Key Milestone in Ox-1 Addiction Program

PremiumCompany Announcements

TheraCryf Achieves Key Milestone in Ox-1 Addiction Program

5M ago

TheraCryf Director Increases Stake, Signaling Confidence in Strategic Direction

PremiumCompany Announcements

TheraCryf Director Increases Stake, Signaling Confidence in Strategic Direction

6M ago

TheraCryf Highlights Mental Health Initiatives and Q4 Conference Plans

PremiumCompany Announcements

TheraCryf Highlights Mental Health Initiatives and Q4 Conference Plans

6M ago

TheraCryf Secures Korean Patent and Advances Ox-1 Development

PremiumCompany Announcements

TheraCryf Secures Korean Patent and Advances Ox-1 Development

7M ago

TheraCryf Advances Ox-1 Development with Manufacturing Scale-Up

PremiumCompany AnnouncementsTheraCryf Advances Ox-1 Development with Manufacturing Scale-Up

9M ago

TheraCryf plc Successfully Passes All Resolutions at AGM

Company Announcements

TheraCryf plc Successfully Passes All Resolutions at AGM

9M ago

TheraCryf plc Reports Significant Progress in Drug Development Programs

Company Announcements

TheraCryf plc Reports Significant Progress in Drug Development Programs

9M ago

TheraCryf plc Releases Annual Report and Announces AGM

PremiumCompany Announcements

TheraCryf plc Releases Annual Report and Announces AGM

10M ago

TheraCryf Appoints New Adviser to Boost Market Position

PremiumCompany Announcements

TheraCryf Appoints New Adviser to Boost Market Position

10M ago

TheraCryf to Host Investor Webinar on Ox-1 Program

PremiumCompany Announcements

TheraCryf to Host Investor Webinar on Ox-1 Program

10M ago

TheraCryf plc Reports Strong Progress and Strategic Focus in 2025 Results

PremiumCompany Announcements

TheraCryf plc Reports Strong Progress and Strategic Focus in 2025 Results

10M ago

TheraCryf Announces Full Year Results and Ox-1 Program Webinar

PremiumCompany AnnouncementsTheraCryf Announces Full Year Results and Ox-1 Program Webinar

11M ago

TheraCryf Plc Announces Major Voting Rights Transfer

Company Announcements

TheraCryf Plc Announces Major Voting Rights Transfer

11M ago

TheraCryf Announces Significant Shareholding Change

Company Announcements

TheraCryf Announces Significant Shareholding Change

11M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >